ReviewCancer cell international2025

Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer.

Hongshu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.